Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4GILEAD SCIENCES INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

US Patent Number : 7176220

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 207561

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2026-08-27

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

ELVITEGRAVIR

US Patent Number : 7176220

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203093

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2026-08-27

blank

03

arrow
BePharma
Not Confirmed

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Patent Number : 7176220

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203100

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2026-08-27

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

ELVITEGRAVIR

US Patent Number : 7176220

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203093

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2026-08-27

blank